Event chart CANOPY GROWTH CORPORATION |
|
|
Upcoming events on CANOPY GROWTH CORPORATION |
|
09/15/22 | 01:00pm | | Annual General Meeting |
11/09/22 | | Interim 2023 Earnings Release |
02/09/23 | | Q3 2023 Earnings Release |
06/27/23 | | FY 2023 Earnings Release (Projected) |
08/14/23 | | Q1 2024 Earnings Release (Projected) |
11/15/23 | | Interim 2024 Earnings Release (Projected) |
02/15/24 | | Q3 2024 Earnings Release (Projected) |
|
Past events on CANOPY GROWTH CORPORATION |
|
08/05/22 | 10:00am | | Q1 2023 Earnings Call |
08/05/22 | 07:15am | | Q1 2023 Earnings Release |
05/27/22 | 10:00am | | FY 2022 Earnings Call |
05/27/22 | 07:00am | | FY 2022 Earnings Release |
04/20/22 | | Benzinga Cannabis Capital Conference |
02/09/22 | 10:00am | | Q3 2022 Earnings Call |
02/09/22 | 07:00am | | Q3 2022 Earnings Release |
11/05/21 | 09:00am | | Interim 2022 Earnings Call |
11/05/21 | 06:02am | | Interim 2022 Earnings Release |
09/14/21 | 02:00pm | | Annual General Meeting |
|
Past dividends on CANOPY GROWTH CORPORATION |
|
- No events available -
|
|
Fiscal Period : March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
Sales M CAD |
Released Forecast Spread | 77,9 79,2 -1,6% | 253 227 12% | 440 421 4,4% | 607 562 8,1% | 582 544 7,0% | 493 |
Operating income (EBITDA) M CAD |
Released Forecast Spread | -41,2 -26,1 -58% | -257 -222 -16% | -443 -431 -2,8% | -340 -310 -9,6% | -415 -354 -17% | -248 |
Operating profit (EBIT) M CAD |
Released Forecast Spread | -82,3 -62,3 -32% | -577 -511 -13% | -1 046 -704 -49% | -1 134 -783 -45% | -713 -652 -9,4% | -599 |
Pre-Tax Profit (EBT) M CAD |
Released Forecast Spread | -52,5 -5,01 -949% | -658 -479 -37% | -1 509 -1 974 24% | -1 684 -1 189 -42% | -329 84,5 -490% | -2 414 |
Net income M CAD |
Released Forecast Spread | -70,4 -26,9 -162% | -685 -450 -52% | -1 321 -1 866 29% | -1 745 -1 106 -58% | -302 88,9 -440% | -2 352 |
EPS CAD |
Released Forecast Spread | -0,40 -0,04 -841% | -2,57 -1,63 -57% | -3,80 -5,78 34% | -4,69 -3,08 -52% | -0,77 0,29 -370% | -5,57 | Announcement Date | 06/27/2018 | 06/20/2019 | 05/29/2020 | 06/01/2021 | 05/27/2022 | - |
|
|
Fiscal Period : March | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 |
Sales M CAD |
Released Forecast Spread | 115 131 -12% | 110 98,6 12% | 135 117 15% | 153 150 1,7% | 167 150 12% | 136 151 -10,0% | 131 143 -8,4% | 141 136 3,8% | 126 130 -3,2% | 110 113 -2,3% | 117 | 129 | 132 | 128 |
Operating income (EBITDA) M CAD |
Released Forecast Spread | -102 -88,0 -16% | -92,2 -104 12% | -85,7 -86,9 1,4% | -68,4 -72,2 5,3% | -94,0 -63,7 -48% | -63,6 -67,4 5,6% | -163 -50,9 -219% | -67,4 -68,8 2,1% | -122 -67,1 -82% | -74,8 -74,4 -0,53% | -62,3 | -51,7 | -55,8 | -41,0 |
Operating profit (EBIT) M CAD |
Released Forecast Spread | -368 -144 -156% | -160 -170 6,2% | -284 -155 -83% | -554 -132 -319% | -232 -111 -110% | -188 -113 -66% | -215 -90,0 -139% | -150 -112 -34% | -289 -149 -93% | -110 -107 -2,6% | -94,3 | -84,1 | -79,4 | -68,5 |
Pre-Tax Profit (EBT) M CAD |
Released Forecast Spread | -1 425 -157 -805% | -131 -175 25% | -96,0 -149 36% | -845 -132 -538% | -612 -104 -485% | 393 -112 452% | -19,5 -95,3 80% | -116 -120 4,0% | -587 -173 -239% | -2 084 -129 -1 515% | -113 | -104 | -98,6 | -88,1 |
Net income M CAD |
Released Forecast Spread | -1 303 -147 -784% | -109 -163 34% | -32,1 -129 75% | -904 -122 -639% | -700 -98,1 -613% | 392 -108 464% | -11,1 -83,1 87% | -109 -128 15% | -575 -169 -240% | -2 083 -122 -1 602% | -112 | -103 | -97,4 | -88,2 |
EPS CAD |
Released Forecast Spread | -3,72 -0,44 -737% | -0,30 -0,46 34% | -0,09 -0,37 76% | -2,43 -0,33 -639% | -1,85 -0,26 -609% | 0,84 -0,27 406% | -0,03 -0,22 87% | -0,28 -0,31 11% | -1,46 -0,49 -198% | -5,23 -0,30 -1 629% | -0,26 | -0,23 | -0,23 | -0,20 | Announcement Date | 05/29/2020 | 08/10/2020 | 11/09/2020 | 02/09/2021 | 06/01/2021 | 08/06/2021 | 11/05/2021 | 02/09/2022 | 05/27/2022 | 08/05/2022 | - | - | - | - | |
|
|
Upcoming sector events for CANOPY GROWTH CORPORATION |
|
08/20/22 | | TASLY PHARMACEUTICAL GROUP CO., LTD : Interim 2022 Earnings Release |
08/20/22 | | DONG-E-E-JIAO CO.,LTD. : Interim 2022 Earnings Release |
08/26/22 | | SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. : Interim 2022 Earnings Release |
08/26/22 | | SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. : Interim 2022 Earnings Release |
08/30/22 | | TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD : Interim 2022 Earnings Release |
10/27/22 | | SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. : Q3 2022 Earnings Release (Projected) |
11/01/22 | | TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD : Q3 2022 Earnings Release (Projected) |
11/01/22 | | TASLY PHARMACEUTICAL GROUP CO., LTD : Q3 2022 Earnings Release (Projected) |
11/01/22 | | SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. : Q3 2022 Earnings Release (Projected) |
11/03/22 | | DONG-E-E-JIAO CO.,LTD. : Q3 2022 Earnings Release (Projected) |
|
|
Past sector events for CANOPY GROWTH CORPORATION |
|
04/29/22 | | TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD : Q1 2022 Earnings Release |
04/29/22 | | SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. : Q1 2022 Earnings Release |
04/29/22 | | DONG-E-E-JIAO CO.,LTD. : Q1 2022 Earnings Release |
04/29/22 | | SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. : FY 2021 Earnings Release |
04/28/22 | | SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. : Q1 2022 Earnings Release |
04/28/22 | | SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. : FY 2021 Earnings Release |
04/26/22 | | TASLY PHARMACEUTICAL GROUP CO., LTD : Q1 2022 Earnings Release |
03/31/22 | | TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD : FY 2021 Earnings Release |
03/26/22 | | DONG-E-E-JIAO CO.,LTD. : FY 2021 Earnings Release |
03/22/22 | | TASLY PHARMACEUTICAL GROUP CO., LTD : FY 2021 Earnings Release |
|
|
|
|
|
Pot producer Canopy Growth posts quarterly loss on charges |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|